Literature DB >> 18350735

Forecasting the declining rate of chronic hepatitis-B carrier status at a Taiwanese university: twenty years after implementation of an universal HBV vaccination program in Taiwan.

Fu-Hsiung Su1, Hsiao-Yun Huang, Hong-Jer Chang, Jin-Ju Jeng, Yi-Hui Liu, Chih-Dao Chen.   

Abstract

BACKGROUND: Prior to the introduction of universal hepatitis B virus (HBV) vaccination in Taiwan in 1984, 15-20% of the general population were chronic HBV carriers.
METHODS: We forecasted and quantified the declining HBV carrier rate 20 years subsequent to the implementation of universal HBV vaccination in Taiwan. At a Taiwanese university, 28,763 freshmen tested for serum HBsAg level were divided into ten age cohorts by date of birth, from July 1976 to June 1986 inclusive. Comparisons of HBsAg carrier rates according to gender were examined with the Z test. Regression methods and a time series model were applied to our sample to forecast trends in changes to the HBsAg carrier rate for the next five years.
RESULTS: Regression analysis demonstrated a trend toward declining HBsAg-positive carrier rates. The HBsAg carrier rate for male students decreased from 16.8% (for those born between July 1976 and June 1977) to 2.2% (for those born between July 1985 and June 1986). The carrier rate for their female counterparts over the same period declined from 12.2% to 2.4%. The HBsAg carrier rate for male participants was significantly greater than that of their female counterparts for certain years during the test period. The results of time series analysis suggests the HBsAg carrier status rate will approach zero for students born after July 1987 (expected to enrol in the university in 2006).
CONCLUSIONS: Our data demonstrate that in order for the HBV carrier rate to approximate zero, universal vaccination programs need to continue for at least 21 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18350735

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  4 in total

1.  Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.

Authors:  Joong-Won Park; Minshan Chen; Massimo Colombo; Lewis R Roberts; Myron Schwartz; Pei-Jer Chen; Masatoshi Kudo; Philip Johnson; Samuel Wagner; Lucinda S Orsini; Morris Sherman
Journal:  Liver Int       Date:  2015-03-25       Impact factor: 5.828

2.  Model of life expectancy of chronic hepatitis B carriers in an endemic region.

Authors:  Tao Wang
Journal:  J Epidemiol       Date:  2009-10-03       Impact factor: 3.211

Review 3.  Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis.

Authors:  Kate Whitford; Bette Liu; Joanne Micallef; J Kevin Yin; Kristine Macartney; Pierre Van Damme; John M Kaldor
Journal:  Bull World Health Organ       Date:  2018-05-14       Impact factor: 9.408

4.  Hepatitis B Virus Screening Before Cancer Chemotherapy in Taiwan: A Nationwide Population-Based Study.

Authors:  Wei-Chih Sun; Pei-Ling Tang; Wen-Chi Chen; Feng-Woei Tsay; Huay-Min Wang; Tzung-Jiun Tsai; Sung-Shuo Kao; Jin-Shiung Cheng; Wei-Lun Tsai
Journal:  Front Med (Lausanne)       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.